-
n this issue: Tamoxifen and CYP2D6 inhibitors, FDA Actions, and FDA Warnings.
-
-
If I were asked to name the 4 most prominent clinical leaders in obstetrics in the United States during its formative years, they would be Hon, Quilligan, Zuspan (who, sadly, passed away in June), and Pritchard.
-
Celiac disease is associated with poor reproductive outcomes, particularly fetal growth restriction, but the mechanisms mediating this association are not understood.
-
Several months ago, Leon asked whether I would take over the duties of editing OB/GYN Clinical Alert. I carefully considered this before agreeing. With so many sources of high-quality information available to clinicians, is OB/GYN Clinical Alert still relevant? What could I bring to ensure the high quality of the publication?
-
Preclinical data recently demonstrated the extreme sensitivity of BRCA-deficient cells to inhibition of the single-strand repair enzyme poly(ADP-ribose) polymerase (PARP).
-
About 30 years ago (so long ago that I can't remember the exact year), I began to edit a monthly newsletter devoted to reproductive medicine.
-
In this issue: Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions.
-
-
A large prospective randomized trial (n = 2812 women) was retrospectively analyzed to look at contraceptive efficacy and weight/BMI.
